TSXV:NRX - Post Discussion
Post by
javaman12 on Jan 14, 2025 10:25pm
2025 Is The Critical Year For FDA Approval!
A near term 'Investigational New Drug' (IND) submission will be quickly followed by Phase I/IIa Human trials to help wheel chair bound victims get up and walking once again! After the IND submission and approval,
Phase 1 trials can commence as early as 30 days later! https://globalregulatorypartners.com/wp-content/uploads/Presentation-1-Overview-of-FDA-Requirements-for-IND-16Feb2020-new-1.pdf NurExone is on the march! Strike up the band! A time of great celebration time is coming our way!
https://media.stockhouse.com/media/companies/v-nrx/eqp/NurExone-Corporate-Presentation-v3-151024.pdf#EQP_SB-PRESENTATION_20241031 Preclinical animal studies have already been done with a 75% success rate. Humans with a new found hope would be strongly motivated to take a greater advantage of physiotherapy strategies to help them get up and walk better to rejoin all the rest of the crowd!
How exciting would that be for them?
This new modern miracle is on its way!
Spinal cord injuries won't need to lock human beings into a wheel chair bound existence for the rest of their lives! That is a new hope that they have never had before!
May the crippled walk once again!
The intial 2025 clinical trials are now set to begin!
All the best! Java
Be the first to comment on this post